Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone with or without sirolimus for newly diagnosed adult ITP
ChiCTR1900020657Phase 4Not yet recruiting
- Sponsor
- Xiniao Hospital
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone and sirolimus in immune thrombocytopenia (ITP) (2 arms), sponsored by Xiniao Hospital. Primary endpoints: Blood routine and Lymphocyte subpopulation. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
dexamethasonesirolimus
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR1900020657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020657.